LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway

References

• Yang Q, Shen XJ, Su ZY, et al. Emerging roles of noncoding RNAs in multiple myeloma: A review. J Cell Physiol. 2019;234(6):7957–7969.
   PubMed Web of Science ®Google Scholar
• Ludwig H, Miguel JS, Dimopoulos MA et al. International Myeloma Working Group recommendations for global myeloma care. Leukemia. 2014;28(5):981–992.
   PubMed Web of Science ®Google Scholar
• Cultrara CN, Kozuch SD, Ramasundaram P, et al. GRP78 modulates cell adhesion markers in prostate cancer and multiple myeloma cell lines. Bmc Cancer. 2018;18:1–14.
   Web of Science ®Google Scholar
• Redondo-Munoz J, Garcia-Pardo A, Teixido J. Molecular players in hematologic tumor cell trafficking. Front Immunol. 2019;10:1–18.
   Web of Science ®Google Scholar
• Wang QY, Lu GP, Chen ZY. MALAT1 promoted cell proliferation and migration via MALAT1/miR-155/MEF2A pathway in hypoxia of cardiac stem cells. J Cell Biochem. 2019;120(4):6384–6394.
   PubMed Web of Science ®Google Scholar
• Zheng LH, Zhang YH, Fu YJ, et al. Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer. Biosci Rep. 2019;39.
   Web of Science ®Google Scholar
• Zhang Y, Wu J, Jing H, et al. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-kappa B and p53. J Cell Biochem. 2019;120(4):6789–6797.
   PubMed Web of Science ®Google Scholar
• Gu Y, Xiao X, Yang S. LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR-509-5p to modulate FOXP1 expression. Oncotarget. 2017;8(60):101984–101993.
   PubMedGoogle Scholar
• Hu Y, Lin JH, Fang H, et al. Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma. Leukemia. 2018;32(10):2250–2262.
   PubMed Web of Science ®Google Scholar
• Cho S-F, Chang YC, Chang C-S, et al. MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression. BMC Cancer. 2014;14(1):809.
   PubMedGoogle Scholar
• Fa-Xing Y, Kun-Liang G. The Hippo pathway: regulators and regulations. Genes Dev. 2013;27(4):355–371.
   PubMed Web of Science ®Google Scholar
• Chai YT, Xiang K, Wu YZ, et al. Cucurbitacin B inhibits the Hippo-YAP signaling pathway and exerts anticancer activity in colorectal cancer cells. Med Sci Monit. 2018;24:9251–9258.
   PubMed Web of Science ®Google Scholar
• Ai A, Xiong Y, Wu BL, et al. Induction of miR-15a expression by tripterygium glycosides caused premature ovarian failure by suppressing the Hippo-YAP/TAZ signaling effector Lats1. Gene. 2018;678:155–163.
   PubMed Web of Science ®Google Scholar
• Beatriz García F, Pedro G, Catarina BP, et al. Actin-capping protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila. Development. 2011;138(5):2337–2346.
   PubMedGoogle Scholar
• Neel JC, Lebrun JJ. Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells. Cell Signal. 2013;25(7):1556–1566.
   PubMed Web of Science ®Google Scholar
• Chang HK, Kim HK, Rettig RL, et al. miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med Genomics. 2011 Nov 23;4(1):79.
   PubMedGoogle Scholar
• Ji J, Yamashita TA. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology. 2010;50(2):472–480.
   Web of Science ®Google Scholar
• Wang F, Sun JY, Zhu YH, et al. MicroRNA-181 inhibits glioma cell proliferation by targeting cyclin B1. Mol Med Rep. 2014;10(4):2160–2164.
   PubMed Web of Science ®Google Scholar
• Wang TY, Zhou QL, Li M, et al. Shikonin alleviates allergic airway remodeling by inhibiting the ERK-NF-κB signaling pathway. Int Immunopharmacol. 2017;48:169.
   PubMed Web of Science ®Google Scholar
• Liu K, Huang J, Ni J, et al. MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142â 3p and miR-129â 5p. Cell Cycle. 2017;16(6):578–587.
   PubMed Web of Science ®Google Scholar
• Zhang TH, Liang LZ, Liu XL, et al. Long non-coding RNA MALAT1 interacts with miR-124 and modulates tongue cancer growth by targeting JAG1. Oncol Rep. 2017;37(4):2087.
   PubMed Web of Science ®Google Scholar
• Li Y, Wu Z, Yuan J, et al. Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis. Cancer Lett. 2017;395(Complete):31.
   PubMedGoogle Scholar
• Shi D, Zhang Y, Lu R, et al. The long non-coding RNA MALAT1 interacted with miR-218 modulates choriocarcinoma growth by targeting Fbxw8. Biomed Pharmacother. 2018;97:543–550.
   PubMed Web of Science ®Google Scholar
• Xu YL, Zhang XH, Hu XF, et al. The effects of lncRNA MALAT1 on proliferation, invasion and migration in colorectal cancer through regulating SOX9. Mol Med. 2018;24:15.
   PubMed Web of Science ®Google Scholar
• Jin Y, Feng SJ, Qiu S, et al. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway. Eur Rev Med Pharmacol Sci. 2017;21(14):3176–3184.
   PubMed Web of Science ®Google Scholar
• Shen H, Weng XD, Liu XH, et al. miR-181a-5p is downregulated and inhibits proliferation and the cell cycle in prostate cancer. Int J Clin Exp Pathol. 2018;11(8):3969–3976.
   PubMed Web of Science ®Google Scholar
• Yang M, Zhai X, Ge TT, et al. miR-181a-5p promotes proliferation and invasion and inhibits apoptosis of cervical cancer cells via regulating inositol polyphosphate-5-phosphatase a (INPP5A). Oncol Res. 2018;26(5):703–712.
   PubMed Web of Science ®Google Scholar
• Chen J, Hu LJ, Chen J, et al. Low expression lncRNA RPLP0P2 is associated with poor prognosis and decreased cell proliferation and adhesion ability in lung adenocarcinoma. Oncol Rep. 2016;36(3):1665–1671.
   PubMed Web of Science ®Google Scholar
• Trenkmann M, Bertoncelj MF, Brock M, et al. Cytokine-mediated repression of the LncRNA hotair enhances intracellular signaling and the expression of adhesion molecules in synovial fibroblasts. Arthritis Rheum. 2013;65:S327–S328.
   Google Scholar
• Hsing EW, Shiah SG, Kuo CC, et al. miRNA-450a suppresses adhesion but promotes invasion through targeting of TMEM182 in oral squamous cell carcinoma. Cancer Res. 2017;77:1475.
   Web of Science ®Google Scholar
• Wang HY, Zhu YC, Zhao MC, et al. miRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin beta 1 and matrix metalloproteinase2 (MMP2). Plos One. 2013;8:8.
   Web of Science ®Google Scholar
• Liu J, Dong HH, Yang YX, et al. Upregulation of long noncoding RNA MALAT1 in papillary thyroid cancer and its diagnostic value. Future Oncol. 2018;14(29):3015–3022.
   PubMed Web of Science ®Google Scholar
• Yan L, Zhang J, Guo D, et al. IL-21R functions as an oncogenic factor and is regulated by the lncRNA MALAT1/miR-125a-3p axis in gastric cancer. Int J Oncol. 2019;54(1):7–16.
   PubMed Web of Science ®Google Scholar
• Ouyang H, Zhou EX, Wang H. Mst1-Hippo pathway triggers breast cancer apoptosis via inducing mitochondrial fragmentation in a manner dependent on JNK-Drp1 axis. Oncol Targets Ther. 2019;12:1147–1159.
   PubMed Web of Science ®Google Scholar
• Zhao W, Zhang LN, Wang XL, et al. Long noncoding RNA NSCLCAT1 increases non-small cell lung cancer cell invasion and migration through the Hippo signaling pathway by interacting with CDH1. Faseb J. 2019;33(1):1151–1166.
   PubMed Web of Science ®Google Scholar
• Deng PF, Zuo Y, Feng SX, et al. Knockdown of NRSF inhibits cell proliferation of ovarian cancer via activating Hippo pathway. Life Sci. 2018;215:73–79.
   PubMed Web of Science ®Google Scholar
• Xie Y, Zhou F, Zhao X. TNFAIP8 promotes cell growth by regulating the Hippo pathway in epithelial ovarian cancer. Exp Ther Med. 2018;16(6):4975–4982.
   PubMed Web of Science ®Google Scholar
• Liu Z, Yao YY, Huang SS, et al. LINC00662 promotes gastric cancer cell growth by modulating the Hippo-YAP1 pathway. Biochem Biophys Res Commun. 2018;505(3):843–849.
   PubMed Web of Science ®Google Scholar
• Song GQ, Zhao Y. MAC30 knockdown involved in the activation of the Hippo signaling pathway in breast cancer cells. Biol Chem. 2018;399(11):1305–1311.
   PubMed Web of Science ®Google Scholar